SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Evotec and Bristol Myers Squibb Advance Partnership With Second IND Acceptance

The companies said their protein degradation partnership has advanced with acceptance of a second investigational new drug application.

Related stories